Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.- Find the Standards of Viable Refereeing: Settling Debates with Strategy
- The most effective method to Promoter for Cutthroat Medical attendant Compensations in Your Medical services Office
- Instructions to Back Your Sunlight powered chargers: Tracking down Possible Choices
- Flu concerns grow in US as UK sees more cases among kids
- St George Mining hits record 178m high-grade intercept at Araxá, reinforcing global scale
- Instructions to Improve Your Mental Exploration with Cutting edge Measurements
- A definitive Manual for Internet Mastering and Expertise Improvement
- No red, no long shorts: The fashion rules Joe Burrows lives by
